A founder mutation in MSH2 in the Ashkenazim.

被引：0
|
作者：
Foulkes, WD
Thiffault, I
Farber, D
Gruber, SB
Offit, K
Bressac-de Paillerets, B
Grandjouan, S
Weitzel, J
Fujimura, F
Gordon, PH
MacNamara, E
Marcus, V
Chong, G
机构：
[1] McGill Univ, Jewish Gen Hosp, SMBD, Montreal, PQ H3T 1E2, Canada
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] CHS Canc Control Ctr, Haifa, Israel
[4] Univ Washington, Seattle, WA 98195 USA
[5] MSKCC, New York, NY USA
[6] Inst Gustave Roussy, Paris, France
[7] City Hope Natl Med Ctr, Ctr Canc, Duarte, CA USA
[8] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2001年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
82
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [1] Origins and prevalence of the American Founder Mutation of MSH2
    Clendenning, Mark
    Baze, Mark E.
    Sun, Shuying
    Walsh, Kyle
    Liyanarachchi, Sandya
    Fix, Dan
    Schunemann, Victoria
    Comeras, Ilene
    Deacon, Molly
    Lynch, Jane F.
    Gong, Gordon
    Thomas, Brittany C.
    Thibodeau, Stephen N.
    Lynch, Henry T.
    Hampel, Heather
    De la Chapelle, Albert
    [J]. CANCER RESEARCH, 2008, 68 (07) : 2145 - 2153
  • [2] Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation
    Lavie, Ofer
    Gruber, Stephen B.
    Lejbkowicz, Flavio
    Dishon, Sara
    Rennert, Gad
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (02) : 148.e1 - 148.e3
  • [3] A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States
    Lynch, HT
    Coronel, SM
    Okimoto, R
    Hampel, H
    Sweet, K
    Lynch, JF
    Barrows, A
    Wijnen, J
    van der Klift, H
    Franken, P
    Wagner, A
    Fodde, R
    de la Chapelle, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (06): : 718 - 724
  • [4] Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome
    Menendez, M.
    Castellvi-Bel, S.
    Pineda, M.
    de Cid, R.
    Munoz, J.
    Gonzalez, S.
    Teule, A.
    Balaguer, F.
    Ramon y Cajal, T.
    Rene, Josep M.
    Blanco, I.
    Castells, A.
    Capella, G.
    [J]. CLINICAL GENETICS, 2010, 78 (02) : 186 - 190
  • [5] Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC
    Stella, A.
    Surdo, N. C.
    Lastella, P.
    Barana, D.
    Oliani, C.
    Tibiletti, M. G.
    Viel, A.
    Natale, C.
    Piepoli, A.
    Marra, G.
    Guanti, G.
    [J]. CLINICAL GENETICS, 2007, 71 (02) : 130 - 139
  • [6] High Risk of Colorectal and Endometrial Cancer in Ashkenazi Families With the MSH2 A636P Founder Mutation
    Mukherjee, Bhramar
    Rennert, Gad
    Ahn, Jaeil
    Dishon, Sara
    Lejbkowicz, Flavio
    Rennert, Hedy S.
    Shiovitz, Stacey
    Moreno, Victor
    Gruber, Stephen B.
    [J]. GASTROENTEROLOGY, 2011, 140 (07) : 1919 - 1926
  • [7] A report of a family with an MSH2 mutation and prostate cancer
    Mundt E.A.
    Knapke S.C.
    Hopkin R.
    [J]. Hereditary Cancer in Clinical Practice, 9 (Suppl 1)
  • [8] MSH2 mutation in Muir-Torre syndrome
    Godard, V
    Coulet, F
    Bernaudin, JF
    Housset, M
    Soubrier, F
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1999, 126 (8-9): : 600 - 603
  • [9] Breast cancer in an MSH2 gene mutation carrier
    Westenend, PJ
    Schütte, R
    Hoogmans, MMCP
    Wagner, A
    Dinjens, WNM
    [J]. HUMAN PATHOLOGY, 2005, 36 (12) : 1322 - 1326
  • [10] MSH2 splice site mutation and endometrial cancer
    Bianchi, F.
    Rosati, S.
    Belvederesi, L.
    Loretelli, C.
    Catalani, R.
    Mandolesi, A.
    Bracci, R.
    Bearzi, I.
    Porfiri, E.
    Cellerino, R.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1419 - 1423
12345